References in periodicals archive ?
Compound SGOT (a) SGPT (b) level level (IU/mL) (IU/mL) Control 85.1 [+ or -] 2.18 * 25.91 [+ or -] 1.13 5h* 84.9 [+ or -] 2.21 25.81 [+ or -] 1.65 5p* 85.6 [+ or -] 1.76 25.94 [+ or -] 1.56 PHY 86.3 [+ or -] 4.12 26.91 [+ or -] 2.20 Compound Alkaline Albumin phosphatase (mg/dL) (IU/mL) Control 15.59 [+ or -] 0.48 1.34 [+ or -] 0.03 5h* 14.98 [+ or -] 0.87 1.46 [+ or -] 0.09 5p* 11.56 [+ or -] 0.36 1.58 [+ or -] 0.06 PHY 13.98 [+ or -] 0.72 1.52 [+ or -] 0.02 Compound Bilirubin (mg/dL) Control 1.56 [+ or -] 0.03 5h* 1.49 [+ or -] 0.07 5p* 1.55 [+ or -] 0.03 PHY 1.57 [+ or -] 0.02 Number of animals tested (n = 6), aserum glutamate oxaloacetate transaminase, bserum glutamate pyruvate transaminase, *P > 0.05 versus control.
Effect of a juvenile hormone analogue on glutamate pyruvate transaminase activity in the bug Pyrrhocoris apterus.
Serum glutamate oxaloacetate transaminase (SGOT) and serum glutamate oxaloacetate pyruvate transaminase (SGPT)
Morphine administration resulted in elevated serum glutamate oxaloacete transaminase and serum glutamate pyruvate transaminase activities.
SGPT: Serum Glutamic Pyruvate Transaminase; SGOT: Serum Glutamic Oxaloacetic Transaminase: ALKP: Alkaline phosphatase Table--3: Effect of Repetitive Heat Stress (4 hours/day at 37 [+ or -] 0.5[degrees]C) on Relative liver wet weight (gm) Experimental Controls 02 Days (n = 6) (n = 6) RLWW 4.85 [+ or -] 0.0567 4.81 [+ or -] 0.0826 (ns) Experimental 05 Days p-value (n = 6) (ANOVA) RLWW 4.85 [+ or -] 0.0569 (ns) >0.05 Values are expressed as Mean [+ or -] SEM.
A colorimetric method for the determination of serum glutamate oxaloacetate and glutamate pyruvate transaminase. Am.
Alanine aminotransferase (glutamate pyruvate transaminase).
The pyruvate is converted to glutamate by serum glutamate pyruvate transaminase. The glutamate gets acted upon by glutamate dehydrogenase to generate alpha ketoglutarate and ammonia.
Abbreviations used: : DNA, deoxy ribonucleic acids; RNA, ribonucleic acids; LDH, lactate dehydrogenase; GOT, glutamate oxaloacetate transaminase; GPT, glutamate pyruvate transaminase; CPK, creatine phosphokinase.
Biochemical parameters, such as serum glutamic oxaloacetate transaminase, serum glutamic pyruvate transaminase (Reitman and Frankel, 1975), alkaline phosphate (Kind and King, 1972), total bilirubin, direct bilirubin (Mally and Evelyn, 1937) and liver glutathione (Ellman, 1959), were analyzed according to the standard method.
Elevated liver enzymes (glutamate oxalacetic transaminase 155 U/L, glutamate pyruvate transaminase 379 U/L) were found, along with elevated lactate dehydrogenase 911 U/L (normal 130-290 U/L) and C-reactive protein 4.9 mg/ dL (normal <0.2 mg/dL).
The heart damage induced by isoproterenol was indicated by elevated levels of the marker enzymes such as Creatine Kinase-isoenzyme (CK-MB), Lactate dehydrogenase (LDH), Serum Glutamate Oxaloacetic Transaminase (SGOT) and Serum Glutamate Pyruvate Transaminase (SGPT) in serum with increased lipid peroxide and reduced glutathione content in heart homogenates.